Triferic is FDA-approved in liquid dialysate, but what is the fate of its IV form pricing-wise and what does that mean for the stock?
Eyegate's OBG solution has a chance for commercialization in 2019
Immunovaccine Inc. (IMV:CA) has released its financial and operational results for the second quarter.
ImmunoVaccine Inc. (IMV: CA) has closed the previously announced bought deal public offering of common shares of the corporation, raising gross proceeds of approximately $10-million.
Sharing Services, Inc. (OTC Markets:SHRV) announced today that it is investing in Medical Smart Care, LLC (“MSC”) and its unique health benefits card program
PreveCeutical Medical Inc. is pleased to announce the appointment of Dr. Harendra (“Harry”) Parekh, Ph.D., BSc., Hons I, as Chief Research Officer (“CRO”).
PreveCeutical Medical Inc. (“PMI”) is pleased to announce that it has signed a research and development agreement effective April 22, 2017 (the "Agreement") with UniQuest Pty Limited.
A look at the frontrunners in one of the fastest growing spaces in healthcare.
Beleave Inc. (CSE: BE) is pleased to announce that it will begin a collaborative research project with Dr. Lesley Campbell, associate professor in the Department of Chemistry and Biology at Ryerson University
Invictus MD Strategies Corp. (CSE:IMH OTC:IVITF FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”)
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
